Attract talent

Richard Chin

Founder & CEO

Richard Chin is a Harvard-trained physician and a former Rhodes Scholar with a track record of almost a dozen drug approvals and over 50 INDs. Drugs Richard developed, including Lucentis®, Xolair®, Tysabri®, and Rituxan® for immune diseases, have current aggregate sales of well over $10 billion per year.

Previously, Richard was Head of Clinical...

Roles at KindredBio

  • Founder & CEO

    Current role

My work style

How I prefer to work

Qualities I value in my colleagues

Sign up to see more about the team at KindredBio

My pet peeves

My communication style

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.